caffeic acid phenethyl ester has been researched along with nsc 664704 in 3 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (nsc 664704) | Trials (nsc 664704) | Recent Studies (post-2010) (nsc 664704) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 95 | 0 | 50 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | nsc 664704 (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8335 | |
| Cyclin-T1 | Homo sapiens (human) | 0.064 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.4 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.47 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.4 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.4243 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 0.4243 | |
| Cyclin-A2 | Homo sapiens (human) | 0.73 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.73 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 9 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.023 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0657 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.064 | |
| Cyclin-A1 | Homo sapiens (human) | 0.73 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.6314 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.6314 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.4 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.4243 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
3 other study(ies) available for caffeic acid phenethyl ester and nsc 664704
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |